SRS. Rodriguez-Jimenez

S. Rodriguez-Jimenez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


S. Rodriguez-Jimenez has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of conditions and diseases associated with systemic inflammation on the plasma concentration of growth differentiation factor 15 (GDF15) in dairy cows

    by S.L. Giesy, J. Opgenorth, S. Rodriguez-Jimenez, L.H. Baumgard, T.H. Swartz, L.K. Mamedova, B.J. Bradford, L.N. Ferro, T.R. Overton, C. Rial, et al.

    Plasma growth differentiation factor 15 (GDF15) was analyzed in dairy cows during the transition period, following treatment with the endotoxin lipopolysaccharide (LPS), during heat stress, and in the presence of infectious diseases. Events associated with these conditions include systemic inflammation and reduced appetite. GDF15 may be relevant to these conditions given its discovery as an overexpressed cDNA in an activated immune cell line and its emergence as an anorexic signal. An i.v. LPS bolus to early lactating cows increased plasma GDF15 from a baseline concentration of 45.2 ± 7.7 pg/mL to a peak concentration of 511.1 ± 92.2 pg/mL within 3 h of administration followed by a return to baseline concentration 33 h later. Dry matter intake over the first 24 h post LPS was negatively related to the area under the curve of plasma GDF15. LPS increased GDF15 expression by 6-fold in liver but had no effect on GDF15 concentration after ex vivo addition to whole blood, identifying liver and not circulating immune cells as a source. In dairy heifers, mammary parenchyma and uterus expressed GDF15 at levels comparable to that of liver, suggesting the capacity of these tissues to increase GDF15 production in response to local endotoxins. In support of this hypothesis, administration of intramammary LPS to early lactating cows raised plasma GDF15 from a baseline concentration of 46.1 ± 4.1 to a peak of 189.3 ± 30.0 pg/mL 9 h later followed by a decline to baseline concentration over the next 15 h. Intramammary LPS caused a 2.1-fold increase in GDF15 expression in liver and a 9.3-fold increase in the mammary gland. We next asked whether plasma GDF15 was increased by naturally occurring events leading to endotoxin exposure (e.g., transition period, heat stress, and infectious diseases). In dairy cows free of clinical diseases, plasma GDF15 increased progressively over the last 3 wk of gestation from 32.6 ± 5.7 pg/mL to a peak of 96.5 ± 22.8 pg/mL on the day of parturition; plasma GDF15 returned to baseline levels by d 3 of lactation and remained at that level over the next 18 d of lactation. Plasma GDF15 was measured over a 7-d period in cows fed ad libitum under thermoneutral or heat stress conditions and in cows fed under thermoneutral conditions to the intake of heat-stressed cows. The reduction of feed intake in pair-fed and heat-stressed cows caused a time-dependent increase in plasma GDF15, but heat stress had no additional effect. Finally, plasma GDF15 was measured in early lactating dairy cows remaining heathy or diagnosed with retained placenta, metritis, or mastitis. Relative to healthy cows, cows with metritis and mastitis had 1.7- and 2.7-fold greater plasma GDF15 concentrations, respectively, whereas cows with retained placenta did not differ. Overall, these data show upregulation of GDF15 production by conditions associated with the presence of endotoxins and raise the possibility that GDF15 may be a member of a highly redundant system designed to reduce appetite during periods of systemic inflammation.

  • Open Access

    The effects of a clay mineral-based feed additive on metabolism and inflammation in heat-stressed lactating dairy cows

    by S. Rodriguez-Jimenez, J. Opgenorth, E.J. Mayorga, M.A. Abeyta, B.M. Goetz, N. Reisinger, J. Faas, R. Palme, L.H. Baumgard


  • Open Access

    Evaluating the effects of zinc hydroxychloride on intestinal barrier permeability and biomarkers of inflammation and metabolism during and following heat stress

    by S. Rodriguez-Jimenez, E.J. Mayorga, M.A. Abeyta, B.M. Goetz, J. Opgenorth, S.K. Kvidera, M.M. McCarthy, K.E. Griswold, L.H. Baumgard

    Heat stress (HS) jeopardizes dairy cow productivity and health. Gastrointestinal tract (GIT) barrier dysfunction appears to be the etiological epicenter of HS-induced pathology. However, the physiology of recovery from HS has scarcely been studied in dairy cows. Thus, objectives were to evaluate the effects of supplemental zinc (Zn) hydroxychloride (HYD) on intestinal barrier permeability, metabolism, and inflammation during and following HS. Holstein cows (n = 24; 130 ± 34 DIM; parity 2 ± 0.5) were balanced by DIM and milk yield and assigned to 1 of 2 ad libitum-fed treatments: (1) control diet (CON; 75 mg/kg Zn from Zn sulfate; n = 12), or (2) HYD (75 mg/kg Zn from HYD; n = 12). Before study initiation, cows were fed their respective diets for 16 d. The trial consisted of 3 experimental periods (P), during which cows continued to receive their respective dietary treatment. Period 1 (5 d) served as the baseline for P2 (5 d), during which HS was artificially induced using electric heat blankets (EHB). During P3 (3 d), the EHB were removed, and cows were allowed to recover in thermoneutral conditions. In vivo total GIT permeability was evaluated on d 4 of P1, d 2 and 4 of P2, and d 2 of P3, using chromium (Cr)-EDTA. As expected, HS increased rectal and skin temperatures (+1.8 and +7.2°C, respectively) and respiration rate (+62 breaths per min) relative to baseline. Heat stress increased Cr appearance (indicative of increased permeability) on both d 2 and 4, and feeding HYD decreased blood Cr appearance on d 2 of P2, with the most pronounced decrease observed during h 1 (29%) relative to controls. Whereas haptoglobin (Hp) concentrations remained constant in CON cows relative to P1, they increased (77%) in HYD-fed cows from d 3 to 5 of HS. During HS recovery, plasma Hp levels remained elevated in HYD and markedly increased in CON (>6-fold) compared with d 5 of P2. Heat stress decreased DMI and milk yield (60% and 42%, respectively) relative to P1. During P3, overall Cr appearance was reduced (reflecting improved barrier function) compared with both P2 and 1. Dry matter intake gradually recovered in both treatments during HS recovery but was increased in HYD-fed cows (10%) relative to CON. Circulating nonesterified fatty acids and BHB progressively increased during HS in both treatments but tended to be lower in HYD from d 3 to 5 (28% and 14%, respectively) relative to CON, and the reducing effects of HYD on BHB continued during the early stage of HS recovery. In summary, HS-induced GIT hyperpermeability, caused inflammation, and altered metabolism; however, whereas inflammation persisted during HS recovery, Cr appearance decreased in P3 compared with P1 and 2. Supplementing HYD improved gut barrier function and modified both metabolism and inflammation during the early stages of HS, and increased DMI during HS recovery.


  • Open Access

    Intermittent and increasing intravenous lipopolysaccharide effect on metabolism, inflammation, and production in lactating dairy cows

    by S. Rodriguez-Jimenez, E.A. Horst, E.J. Mayorga, M.A. Abeyta, B.M. Goetz, L.H. Baumgard

    Experimental objectives were to create a chronic inflammatory model to evaluate the effects of persistent immune activation on metabolism, inflammation, and productivity in lactating dairy cows. Twelve lactating Holstein cows (631 ± 16 kg BW; 124 ± 15 DIM) were enrolled in a study with 2 experimental periods (P); during P1 (5 d), cows were fed ad libitum and baseline data were obtained. At the initiation of P2 (7 d), cows were assigned to 1 of 2 treatments: 1) saline-infused and pair-fed (PF; 5 mL intravenously (IV) sterile saline on d 1, 3, and 5; n = 6) or 2) lipopolysaccharide infused and ad libitum-fed (LPS; 0.2, 0.8, and 1.6 µg LPS/kg BW IV on d 1, 3, and 5, respectively; n = 6). Blood samples were collected on d 3 and 5 of P1, and d 1, 3, 5, and 7 of P2. Administering LPS induced a febrile response (∼6 h duration) following each bolus (+0.6, 0.6, and 0.8°C, for d 1, 3 and 5, respectively). Lipopolysaccharide-binding protein, serum amyloid A, and haptoglobin concentrations increased in LPS-administered cows relative to baseline and PF animals. Cholesterol and albumin concentrations decreased in LPS relative to PF cows and effects were most prominent from d 3-7 of P2. Circulating cortisol in LPS-infused cows progressively increased during P2 (63% on d 7) relative to PF cows. Overall, during P2, LPS administration induced a sawtooth pattern in dry matter intake (DMI) and the negative consequences on DMI ameliorated as P2 progressed. By design, the DMI pattern in PF cows was similar to their LPS counterparts. Administering LPS also created a reciprocating response in milk yield that lessened as P2 progressed. Overall, milk yield was decreased in LPS and PF cows compared with P1 (29 and 10%, respectively). Circulating insulin decreased in both treatments relative to P1, but the decrease was more severe in PF (61%) compared with LPS infused cows (27%). Relative to PF cows, nonesterified fatty acids (NEFA) remained similar to P1 in LPS administered cows, but increased (3.2-fold) in PF cows. Ionized calcium decreased in LPS cows compared with PF controls. In summary, alternating and increasing LPS doses caused chronic inflammation, markedly altered metabolism, and temporarily decreased DMI and milk synthesis. However, while the acute phase proteins remained elevated throughout P2, the effect on production lessened with time.


  • Open Access

    Intramammary lipopolysaccharide challenge in early- versus mid-lactation dairy cattle: Immune, production, and metabolic responses

    by J. Opgenorth, J. Opgenorth, M.A. Abeyta, M.A. Abeyta, B.M. Goetz, B.M. Goetz, S. Rodriguez-Jimenez, S. Rodriguez-Jimenez, A.D. Freestone, A.D. Freestone, et al.

    Study objectives were to compare the immune response, metabolism and production following intramammary lipopolysaccharide (IMM LPS) administration in early and mid-lactation cows. Early (E-LPS; n = 11; 20 ± 4 d in milk [DIM]) and mid- (M-LPS; n = 10; 155 ± 40 DIM) lactation cows were enrolled in an experiment consisting of 2 periods (P). During P1 (5 d) cows were fed ad libitum and baseline data were collected, including liver and muscle biopsies. At the beginning of P2 (3 d) cows received 10 mL sterile saline containing 10 µg of LPS from Escherichia coli O111:B4/mL into the left rear quarter of the mammary gland, and liver and muscle biopsies were collected at 12 h post-LPS. Tissues were analyzed for metabolic flexibility, which measures substrate switching capacity from pyruvic acid to palmitic acid oxidation. Data were analyzed with the MIXED procedure in SAS 9.4. Rectal temperature was assessed hourly for the first 12 h post-LPS and every 6 h thereafter for the remainder of P2. All cows developed a febrile response following LPS, but E-LPS had a more intense fever than M-LPS cows (0.7°C at 5 h after LPS). Blood samples were collected at 0, 3, 6, 9, 12, 24, 36, 48, and 72 h post-LPS for analysis of systemic inflammation and metabolism parameters. Total serum Ca decreased after LPS (26% at 6 h nadir) but did not differ by lactation stage (LS). Circulating neutrophils decreased, then increased post-LPS in both LS, but E-LPS had exaggerated neutrophilia (56% from 12 to 48 h) compared with M-LPS. Haptoglobin increased after LPS (15-fold) but did not differ by LS. Many circulating cytokines were increased post-LPS, and IL-6, IL-10, TNF-α, MCP-1, and IP-10 were further augmented in E-LPS compared with M-LPS cows. Relative to P1, all cows had reduced milk yield (26%) and dry matter intake (DMI; 14%) on d 1 that did not differ by lactation stage (LS). Somatic cell score increased rapidly in response to LPS regardless of LS and gradually decreased from 18 h onwards. Milk component yields decreased after LPS. However, E-LPS had increased fat (11%) and tended to have increased lactose (8%) yield compared with M-LPS cows throughout P2. Circulating glucose was not affected by LPS. Nonesterified fatty acids (NEFA) decreased in E-LPS (29%) but not M-LPS cows. β-hydroxybutyrate (BHB) slightly increased (14%) over time post-LPS regardless of LS. Insulin increased after LPS in all cows, but E-LPS had blunted hyperinsulinemia (52%) compared with M-LPS cows. Blood urea nitrogen (BUN) increased after LPS and the relative change in BUN was elevated in E-LPS cows compared with M-LPS cows (36 and 13%, respectively, from 9 to 24 h). During P1, metabolic flexibility was increased in liver and muscle in early lactating cows compared with mid-lactation cows, but 12 h post-LPS, metabolic flexibility was reduced and did not differ by LS. In conclusion, IMM LPS caused severe immune activation and E-LPS cows had a more intense inflammatory response compared with M-LPS cows, but the effects on milk synthesis was similar between LS. Some parameters of the E-LPS metabolic profile suggest continuation of metabolic adjustments associated with early lactation to support both a robust immune system and milk synthesis.


  • Open Access

    Intravenous lipopolysaccharide challenge in early- versus mid-lactation dairy cattle. II: The production and metabolic responses

    by J. Opgenorth, E.J. Mayorga, M.A. Abeyta, S. Rodriguez-Jimenez, B.M. Goetz, A.D. Freestone, L.H. Baumgard

    Most immunometabolic research utilizes mid-lactation (ML) cows. Cows in early lactation (EL) are in a presumed state of immune suppression/dysregulation and less is known about how they respond to a pathogen. Study objectives were to compare the production and metabolic responses to i.v. lipopolysaccharide (LPS) and to differentiate between the direct effects of immune activation and the indirect effects of illness-induced hypophagia in EL and ML cows. Cows in EL (n = 11; 20 ± 2 d in milk) and ML (n = 12; 131 ± 31 d in milk) were enrolled in a 2 × 2 factorial design containing 2 experimental periods (P). During P1 (3 d), cows were fed ad libitum and baseline data were collected. At the initiation of P2 (3 d), cows were randomly assigned to 1 of 2 treatments by lactation stage (LS): (1) EL (EL-LPS; n = 6) or ML (ML-LPS; n = 6) cows administered i.v. a single bolus of 0.09 µg LPS/kg of body weight; Escherichia coli O55:B5 or (2) pair-fed (PF) EL (EL-PF; n = 5) or ML (ML-PF; n = 6) cows administered i.v. saline. Administering LPS decreased dry matter intake (DMI) and this was more severe in EL-LPS than ML-LPS cows (34 and 11% relative to baseline, respectively). By design, P2 DMI patterns were similar in the PF groups compared with their LPS counterparts. Milk yield decreased following LPS (42% on d 1 relative to P1) and despite an exacerbated decrease in EL-LPS cows on d 1 (25% relative to ML-LPS), remained similar between LS from d 2-3. EL-LPS had increased milk fat content, but no difference in protein and lactose percentages compared with ML-LPS cows. Further, cumulative ECM yield was increased (21%) in EL-LPS compared with ML-LPS cows. During P2, EL-LPS cows had a more intense increase in milk urea nitrogen (MUN) and blood urea nitrogen (BUN) than ML-LPS and EL-PF cows. Administering LPS did not cause hypoglycemia in either EL-LPS or ML-LPS cows, but glucose was increased (33%) in EL-LPS compared with EL-PF. Hyperinsulinemia occurred post-LPS, and insulin was further increased in ML-LPS than EL-LPS cows (2.2-fold at 12 h peak). During P2, circulating glucagon increased only in EL-LPS cows (64% relative to all other groups). Both EL groups had increased NEFA at 3 and 6 h post-LPS from baseline (56%), but NEFA in EL-LPS cows gradually returned to baseline thereafter and were reduced relative to EL-PF until 36 h (50% from 12 to 24 h). Alterations in β-hydroxybutyrate (BHB) did not differ between ML groups, but EL-LPS had reduced BHB compared with EL-PF from 24 to 72 h (51%). Results indicate that there are distinct LS differences in the anorexic and metabolic responses to immune activation. Collectively, EL cows are more sensitive to the catabolic effects of LPS than ML cows, but these exacerbated metabolic responses appear coordinated to fuel an augmented immune system while simultaneously supporting milk synthesis.


  • Open Access

    Intravenous lipopolysaccharide challenge in early- versus mid-lactation dairy cattle. I: The immune and inflammatory responses

    by J. Opgenorth, E.J. Mayorga, M.A. Abeyta, B.M. Goetz, S. Rodriguez-Jimenez, A.D. Freestone, J.L. McGill, L.H. Baumgard

    Cows in early lactation (EL) are purportedly immune suppressed, which renders them more susceptible to disease. Thus, the study objective was to compare key biomarkers of immune activation from i.v. LPS between EL and mid-lactation (ML) cows. Multiparous EL (20 ± 2 DIM; n = 11) and ML (131 ± 31 DIM; n = 12) cows were enrolled in a 2 × 2 factorial design and assigned to 1 of 2 treatments by lactation stage (LS): (1) EL (EL-LPS; n = 6) or ML (ML-LPS; n = 6) cows administered a single LPS bolus from Escherichia coli O55:B5 (0.09 µg/kg of BW), or (2) pair-fed (PF) EL (EL-PF; n = 5) or ML (ML-PF; n = 6) cows administered i.v. saline. After LPS administration, cows were intensely evaluated for 3 d to analyze their response and recovery to LPS. Rectal temperature increased in LPS relative to PF cows (1.1°C in the first 9 h), and the response was more severe in EL-LPS relative to ML-LPS cows (2.3 vs. 1.3°C increase at 4 h post-LPS; respectively). Respiration rate increased only in EL-LPS cows (47% relative to ML-LPS in the first hour post-LPS). Circulating tumor necrosis factor-α, IL-6, monocyte chemoattractant protein-1, macrophage inflammatory protein (MIP)-1α, MIP-1β, and IFN-γ-inducible protein-10 increased within the first 6 h after LPS and these changes were exacerbated in EL-LPS relative to ML-LPS cows (6.3-fold, 4.8-fold, 57%, 93%, 10%, and 61%, respectively). All cows administered LPS had decreased circulating iCa relative to PF cows (34% at the 6 h nadir), but the hypocalcemia was more severe in EL-LPS than ML-LPS cows (14% at 6 h nadir). In response to LPS, neutrophils decreased regardless of LS, then increased into neutrophilia by 24 h in all LPS relative to PF cows (2-fold); however, the neutrophilic phase was augmented in EL- compared with ML-LPS cows (63% from 24 to 72 h). Lymphocytes and monocytes rapidly decreased then gradually returned to baseline in LPS cows regardless of LS; however, monocytes were increased (57%) at 72 h in EL-LPS relative to ML-LPS cows. Platelets were reduced (46%) in LPS relative to PF cows throughout the 3-d following LPS, and from 24 to 48 h, platelets were further decreased (41%) in EL-LPS compared with ML-LPS. During the 3-d following LPS, serum amyloid A (SAA), LPS-binding protein (LBP), and haptoglobin (Hp) increased in LPS compared with PF groups (9-fold, 72%, and 153-fold, respectively), and the LBP and Hp responses were more exaggerated in EL-LPS than ML-LPS cows (85 and 79%, respectively) whereas the SAA response did not differ by LS. Thus, our data indicates that EL immune function does not appear "suppressed," and in fact many aspects of the immune response are seemingly functionally robust.


  • Open Access

    Effects of hindgut acidosis on inflammation, metabolism, and productivity in lactating dairy cows fed a high-fiber diet

    by M.A. Abeyta, E.A. Horst, B.M. Goetz, S. Rodriguez-Jimenez, E.J. Mayorga, M. Al-Qaisi, L.H. Baumgard

    Hindgut acidosis (HGA) may cause or contribute to the inflammatory state of transition dairy cows by compromising the intestinal barrier. Previous experiments isolating the effects of HGA on inflammatory metrics have generated inconsistent results, which may be explained by acclimation to low- versus high-starch diets. Thus, study objectives were to evaluate the effects of HGA in cows acclimated to a high-fiber diet. Ten rumen-cannulated Holstein cows (38 ± 5 kg/d milk yield; 243 ± 62 d in milk; 1.6 ± 1.1 parity; 663 ± 57 kg of body weight) were enrolled in a study with 2 experimental periods (P). Before P1, all cows were acclimated to a high-fiber, low-starch diet (50% neutral detergent fiber, 15% starch) for 17 d. During P1 (4 d), baseline data were collected for use as covariates. During P2 (7 d), cows were assigned to 1 of 2 abomasal infusion treatments: (1) control (CON; 1.5 L of H2O/infusion; n = 4) or (2) starch infused (ST; 1 kg of corn starch + 1.5 L of H2O/infusion; n = 6). All cows were infused with their respective treatments every 6 h daily at 0000, 0600, 1200, and 1800 h, such that ST cows received a total of 4 kg of corn starch/d. Starch infusions successfully induced HGA, as indicated by a marked decrease in fecal pH (1.2 units) relative to CON. However, in contrast to our assumptions, infusing starch had no deleterious effects on milk yield, energy-corrected milk, or voluntary dry matter intake during P2. Milk protein, lactose, their yields, fat yield, and somatic cell score remained unaffected by starch infusions, whereas milk fat content and urea nitrogen were decreased in ST relative to CON (8 and 17%, respectively). Overall, circulating glucose and β-hydroxybutyrate concentrations remained similar between treatments, but starch infusions decreased nonesterified fatty acids on d 3 relative to CON. Blood urea nitrogen decreased throughout P2 in ST (38%) relative to CON. In contrast to our hypothesis, HGA did not alter circulating serum amyloid A or lipopolysaccharide binding protein, nor did it affect rectal temperature. In summary, HGA moderately altered metabolism but did not affect production or elicit an inflammatory response in lactating dairy cows previously acclimated to a high-fiber diet.


  • Open Access

    Effects of dietary antioxidant supplementation on metabolism and inflammatory biomarkers in heat-stressed dairy cows

    by M.A. Abeyta, M. Al-Qaisi, E.A. Horst, E.J. Mayorga, S. Rodriguez-Jimenez, B.M. Goetz, S. Carta, H. Tucker, L.H. Baumgard

    Heat-stress-induced inflammation may be ameliorated by antioxidant supplementation due to the purported effects of increased production of reactive oxygen species or oxidative stress on the gastrointestinal tract barrier. Thus, study objectives were to evaluate whether antioxidant supplementation [AGRADO Plus 2.0 (AP); EW Nutrition] affects metabolism and inflammatory biomarkers in heat-stressed lactating dairy cows. Thirty-two mid-lactation multiparous Holstein cows were assigned to 1 of 4 dietary-environmental treatments: (1) thermoneutral (TN) conditions and fed a control diet (TN-CON; n = 8), (2) TN and fed a diet with AP (10 g antioxidant; n = 8), (3) heat stress (HS) and fed a control diet (HS-CON; n = 8), or (4) HS and fed a diet with AP (HS-AP; n = 8). The trial consisted of a 23-d prefeeding phase and 2 experimental periods (P). Respective dietary treatments were top-dressed starting on d 1 of the prefeeding period and continued daily throughout the duration of the experiment. During P1 (4 d), baseline data were collected. During P2 (7 d), HS was artificially induced using an electric heat blanket (Thermotex Therapy Systems Ltd.). During P2, the effects of treatment, day, and treatment-by-day interaction were assessed using PROC MIXED of SAS (SAS Institute Inc.). Heat stress (treatments 3 and 4) increased rectal, vaginal, and skin temperatures (1.2°C, 1.1°C, and 2.0°C, respectively) and respiration rate (33 breaths per minute) relative to TN cows. As expected, HS decreased dry matter intake, milk yield, and energy-corrected milk yield (32%, 28%, and 28% from d 4 to 7, respectively) relative to TN. There were no effects of AP on body temperature indices or production. Milk fat, protein, and lactose concentrations remained unaltered by HS or AP; however, milk urea nitrogen was increased during HS regardless of AP supplementation (26% relative to TN). Circulating glucose remained unchanged by HS, AP, or time. Additionally, HS decreased circulating glucagon (29% from d 3 to 7 relative to TN), but there was no additional effect of AP. There was a tendency for nonesterified fatty acid concentrations to be increased in HS-AP cows throughout P2 (60% relative to TN-CON), whereas it remained similar in all other treatments. Blood urea nitrogen increased for both HS treatments from d 1 to 3 before steadily decreasing from d 5 to 7, with the overall increase being most pronounced in HS-CON cows (27% relative to TN-CON). Further, supplementing AP decreased blood urea nitrogen in HS-AP on d 3 relative to HS-CON (15%). Circulating serum amyloid A tended to be and lipopolysaccharide binding protein was increased by HS, but neither acute-phase protein was affected by AP. Overall, AP supplementation appeared to marginally alter metabolism but did not meaningfully alter inflammation during HS.